Lansoprazole patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11077055 DEXCEL PHARMA Orally disintegrating compositions
Apr, 2036

(12 years from now)

Lansoprazole is owned by Dexcel Pharma.

Lansoprazole contains Lansoprazole.

Lansoprazole has a total of 1 drug patent out of which 0 drug patents have expired.

Lansoprazole was authorised for market use on 07 June, 2016.

Lansoprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.

The generics of Lansoprazole are possible to be released after 21 April, 2036.

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 07 June, 2016

Treatment: NA


More Information on Dosage

LANSOPRAZOLE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic